William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 5,815 shares at $28.79 ($167K) on 2024-10-16, disclosed to the SEC on 2024-10-18.
Open-market sale of $167k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.79 | 561 | $16K | 9.6% |
| 2 | $28.79 | 2,627 | $76K | 45.2% |
| 3 | $28.79 | 2,627 | $76K | 45.2% |
| Total | $28.79 avg | 5,815 | $167K | 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $160K | — | Filing → |